Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).

NCT00741325 · clinicaltrials.gov ↗

COMPLETED

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin's Lymphoma
Autologous Transplantation

Interventions

DRUG: granulocyte colony-stimulating factor (G-CSF)
DRUG: plerixafor
DRUG: Placebo

Sponsor

Genzyme, a Sanofi Company